Analyst Consensus ?
ConsensusHold23 ratings
Bullish1356.5%
Neutral939.1%
Bearish14.4%
FN2 Earnings Intelligence
IDEXX Laboratories, Inc. complete analyst coverage
IDEXX Laboratories, Inc. (IDXX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$561.25Previous close
$247Low
$643.72Average
$830High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Oct 16, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 11, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Stifel | Buy | Buy | Maintain | Mar 31, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Feb 9, 2026 |
| BTIG | Buy | Buy | Maintain | Feb 3, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 4, 2025 |
| Leerink Partners | Outperform | Outperform | Maintain | Jul 17, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 21, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 17, 2024 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Aug 2, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 13, 2021 |
| Guggenheim | Neutral | Buy | Downgrade | Jul 12, 2021 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 22, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | May 2, 2019 |
| Bank of America | Buy | Buy | Maintain | Nov 2, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jan 16, 2018 |
| Aegis Capital | Sell | Sell | Maintain | Jun 1, 2017 |
| CL King | Neutral | Neutral | Maintain | Apr 1, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Aug 28, 2015 |
| Feltl & Co. | Hold | Sell | Upgrade | Jul 23, 2015 |
| Bank oferica | Buy | Buy | Maintain | Apr 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $561.25. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $627 | $562.47 | +11.7% | Oct 27, 2026 |
| Goldman Sachs | Matt Dellatorre | $740 | $547.18 | +31.8% | Oct 16, 2026 |
| Barclays | Glen Santangelo | $710 | $595.76 | +26.5% | Aug 11, 2026 |
| UBS | Analyst unavailable | $620 | $559.86 | +10.5% | Jul 27, 2026 |
| UBS | Andrea Alfonso | $640 | $569.17 | +14.0% | Apr 28, 2026 |
| Piper Sandler | Analyst unavailable | $750 | $644.61 | +33.6% | Feb 9, 2026 |
| Barclays | Glen Santangelo | $800 | $642.94 | +42.5% | Feb 5, 2026 |
| UBS | Andrea Alfonso | $730 | $639.6 | +30.1% | Feb 3, 2026 |
| BTIG | Analyst unavailable | $800 | $639.6 | +42.5% | Feb 3, 2026 |
| Barclays | Glen Santangelo | $850 | $706.65 | +51.4% | Dec 8, 2025 |
| Morgan Stanley | Analyst unavailable | $805 | $721.04 | +43.4% | Nov 4, 2025 |
| UBS | Analyst unavailable | $750 | $722.94 | +33.6% | Nov 4, 2025 |
| BTIG | Analyst unavailable | $830 | $722.94 | +47.9% | Nov 4, 2025 |
| Jefferies | Keith Devas | $830 | $722.94 | +47.9% | Nov 4, 2025 |
| Leerink Partners | Analyst unavailable | $785 | $722.94 | +39.9% | Nov 3, 2025 |
| Stifel Nicolaus | Jonathan Block | $775 | $722.94 | +38.1% | Nov 3, 2025 |
| Stifel Nicolaus | Jonathan Block | $700 | $628.54 | +24.7% | Oct 31, 2025 |
| UBS | Andrea Alfonso | $720 | $638.89 | +28.3% | Oct 1, 2025 |
| Morgan Stanley | Analyst unavailable | $722 | $641.94 | +28.6% | Aug 5, 2025 |
| BTIG | Analyst unavailable | $785 | $641.94 | +39.9% | Aug 5, 2025 |
| Stifel Nicolaus | Analyst unavailable | $640 | $682.78 | +14.0% | Aug 4, 2025 |
| Stifel Nicolaus | Jonathan Block | $510 | $495.73 | -9.1% | Jun 24, 2024 |
| Barclays | Analyst unavailable | $590 | $507.68 | +5.1% | Feb 8, 2023 |
| J.P. Morgan | Analyst unavailable | $550 | $487.04 | -2.0% | Feb 7, 2023 |
| Atlantic Equities | Analyst unavailable | $600 | $485.53 | +6.9% | Feb 7, 2023 |
| Oppenheimer | Analyst unavailable | $247 | $483.2 | -56.0% | Feb 2, 2023 |
| Citigroup | Analyst unavailable | $268 | $483.2 | -52.2% | Feb 2, 2023 |
| Citigroup | Analyst unavailable | $273 | $420.63 | -51.4% | Dec 9, 2022 |
| Morgan Stanley | Analyst unavailable | $543 | $435.78 | -3.3% | Nov 15, 2022 |
| Stifel Nicolaus | Analyst unavailable | $500 | $355.62 | -10.9% | Jun 24, 2022 |
| Goldman Sachs | Analyst unavailable | $530 | $357.33 | -5.6% | May 19, 2022 |
| Barclays | Balaji Prasad | $700 | $364.5 | +24.7% | May 6, 2022 |
Track every rating change on IDXX the moment it posts. Free to start.
Start freeGet the IDXX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.